{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:01:02Z","timestamp":1756425662693,"version":"3.44.0"},"reference-count":11,"publisher":"Human Kinetics","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:p><jats:italic><jats:bold>Purpose<\/jats:bold>:<\/jats:italic> To examine the effect of growth hormone (GH) treatment on physical performance in children with idiopathic short stature and normal GH secretion. <jats:italic><jats:bold>Materials and Methods<\/jats:bold><\/jats:italic><jats:bold>:<\/jats:bold> A total of 24 children participated in the study (13 GH-treated, 11 non-treated, aged 8\u201313\u00a0y, 11 males and 13 females, Tanner stage 1\u20132). Participants performed a battery of motor skill performance tests (Eurofit), as well as the Wingate anaerobic test. <jats:italic><jats:bold>Results<\/jats:bold>:<\/jats:italic> No statistically significant differences in any of the Eurofit physical fitness test results (eg,\u00a020-m shuttle run 33.0 [15.1] vs 25.1 [21.0] laps in treated and nontreated participants, respectively, <jats:italic>P<\/jats:italic>\u2009=\u2009.25) or the Wingate anaerobic test were found between the groups (eg,\u00a0peak power 5.0 [2.9] vs 3.9 [2.6]\u00a0watts\/kg in treated and nontreated participants, respectively, <jats:italic>P<\/jats:italic>\u2009=\u2009.2). <jats:italic><jats:bold>Conclusions<\/jats:bold>:<\/jats:italic> Therapeutic usage of exogenous GH for pre and early pubertal children with idiopathic short stature and normal GH secretion was not associated with beneficial effects on physical performance indices. This suggests that the use of GH as a potential performance enhancing agent, in this age group, at least at commonly used doses, is not advantageous.<\/jats:p>","DOI":"10.1123\/pes.2020-0061","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T12:30:18Z","timestamp":1617971418000},"page":"70-73","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Growth Hormone Treatment on Physical Performance Indices in Children With Idiopathic Short Stature"],"prefix":"10.1123","volume":"33","author":[{"given":"Adi","family":"Weinberg","sequence":"first","affiliation":[{"name":"Tel Aviv University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitzan","family":"Dror","sequence":"additional","affiliation":[{"name":"Tel Aviv University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya","family":"Motin","sequence":"additional","affiliation":[{"name":"Tel Aviv University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Pantanowitz","sequence":"additional","affiliation":[{"name":"Tel Aviv University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Nemet","sequence":"additional","affiliation":[{"name":"Tel Aviv University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Eliakim","sequence":"additional","affiliation":[{"name":"Tel Aviv University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"100","reference":[{"issue":"6","key":"r1","series-title":"Sports Med","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00007256-198704060-00001","article-title":"The Wingate anaerobic test. An update on methodology, reliability and validity","volume":"4","author":"Bar-Or O","year":"1987","unstructured":"Bar-Or O. The Wingate anaerobic test. An update on methodology, reliability and validity. Sports Med. 1987;4(6):381\u201394. PubMed ID: 3324256 doi:10.2165\/00007256-198704060-00001332425610.2165\/00007256-198704060-00001"},{"issue":"11","key":"r2","series-title":"J Clin Endocrinol Metab","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1210\/jc.2017-00871","article-title":"Growth hormone improves cardiopulmonary capacity and body composition in children with growth hormone deficiency","volume":"102","author":"Capalbo D","year":"2017","unstructured":"Capalbo D, Barbieri F, Improda N, et\u00a0al. Growth hormone improves cardiopulmonary capacity and body composition in children with growth hormone deficiency. J Clin Endocrinol Metab. 2017;102(11):4080\u20138. PubMed ID: 28938456 doi:10.1210\/jc.2017-008712893845610.1210\/jc.2017-00871"},{"issue":"11","key":"r3","series-title":"J Clin Endocrinol Metab","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1210\/jc.2008-0509","article-title":"Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop","volume":"93","author":"Cohen P","year":"2008","unstructured":"Cohen P, Rogol AD, Deal CL, et\u00a0al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93(11):4210\u20137. PubMed ID: 18782877 doi:10.1210\/jc.2008-050910.1210\/jc.2008-0509"},{"issue":"5","key":"r4","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11102-019-00979-3","article-title":"Static and dynamic balances of patients with acromegaly and impact of exercise on balance","volume":"22","author":"Haliloglu O","year":"2019","unstructured":"Haliloglu O, Topsakal N, Camliguney F, et\u00a0al. Static and dynamic balances of patients with acromegaly and impact of exercise on balance. Pituitary. 2019;22(5):497\u2013506. PubMed ID: 31368031 doi:10.1007\/s11102-019-00979-310.1007\/s11102-019-00979-331368031"},{"key":"r5","series-title":"Growth Horm IGF Res","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ghir.2017.05.005","article-title":"Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials","volume":"34","author":"Hermansen K","year":"2017","unstructured":"Hermansen K, Bengtsen M, Kjaer M, Vestergaard P, Jorgensen JOL. Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials. Growth Horm IGF Res. 2017;34:38\u201344. PubMed ID: 28514721 doi:10.1016\/j.ghir.2017.05.00510.1016\/j.ghir.2017.05.00528514721"},{"key":"r6","series-title":"Adv Data","first-page":"1","article-title":"CDC growth charts: United States","volume":"314","author":"Kuczmarski RJ","year":"2000","unstructured":"Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et\u00a0al. CDC growth charts: United States. Adv Data. 2000;314:1\u201327."},{"issue":"1","key":"r7","series-title":"Eur J Appl Physiol Occup Physiol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00428958","article-title":"A maximal multistage 20-m shuttle run test to predict VO2max","volume":"49","author":"Leger LA","year":"1982","unstructured":"Leger LA, Lambert J. A maximal multistage 20-m shuttle run test to predict VO2max. Eur J Appl Physiol Occup Physiol. 1982;49(1):1\u201312. PubMed ID: 720192210.1007\/BF004289587201922"},{"issue":"16 Suppl 1","key":"r8","series-title":"Pediatr Endocrinol Rev","first-page":"142","article-title":"rhGH Abuse for Sports Performance","author":"Rogol AD","year":"2018","unstructured":"Rogol AD. rhGH Abuse for Sports Performance. Pediatr Endocrinol Rev. 2018;(16 Suppl 1):142\u20139. PubMed ID: 3037879230378792"},{"issue":"4","key":"r9","series-title":"J Sports Sci","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/02640419808559361","article-title":"Prediction of maximal oxygen uptake from a 20-m shuttle run as measured directly in runners and squash players","volume":"16","author":"St Clair GA","year":"1998","unstructured":"St Clair GA, Broomhead S, Lambert MI, Hawley JA. Prediction of maximal oxygen uptake from a 20-m shuttle run as measured directly in runners and squash players. J Sports Sci. 1998;16(4):331\u20135. doi:10.1080\/0264041980855936110.1080\/02640419808559361"},{"key":"r10","series-title":"Med Sport Sci","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000101355","article-title":"Who are the Eurofittest?","volume":"50","author":"Tomkinson GR","year":"2007","unstructured":"Tomkinson GR, Olds TS, Borms J. Who are the Eurofittest? Med Sport Sci. 2007;50:104\u201328. PubMed ID: 1738725410.1159\/00010135517387254"},{"year":"2020","key":"r11","unstructured":"World Anti-Doping Agency: List of prohibited substances and methods. 2020. https:\/\/www.wada-ama.org\/en\/media\/news\/2019-09\/wada-publishes-2020-list-of-prohibited-substances-and-methods"}],"container-title":["Pediatric Exercise Science"],"original-title":[],"link":[{"URL":"https:\/\/journals.humankinetics.com\/view\/journals\/pes\/33\/2\/article-p70.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.humankinetics.com\/downloadpdf\/journals\/pes\/33\/2\/article-p70.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.humankinetics.com\/downloadpdf\/journals\/pes\/33\/2\/article-p70.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T23:09:04Z","timestamp":1756336144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.humankinetics.com\/view\/journals\/pes\/33\/2\/article-p70.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":11,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1123\/pes.2020-0061","relation":{},"ISSN":["0899-8493","1543-2920"],"issn-type":[{"type":"print","value":"0899-8493"},{"type":"electronic","value":"1543-2920"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}